[1]
Prabhakar, N. et al. 2024. Elderly (> 70 years) Multiple Myeloma Patients Benefit Equally from Autologous Hematopoietic Stem Cell Transplantation When Compared to Younger Patients. Journal of Stem Cell Therapy and Transplantation. 8, 1 (Aug. 2024), 042–047. DOI:https://doi.org/10.29328/journal.jsctt.1001042.